W
PFE icon

WealthCollab’s Pfizer PFE Stock Holding History

WealthCollab’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121K Buy
5,017
+570
+13% +$14.9K 0.04% 121
2026
Q1 		$125K Hold
4,447
– – 0.05% 103
2025
Q4 		$111K Buy
4,447
+300
+7% +$7.57K 0.05% 115
2025
Q3 		$106K Buy
4,147
+162
+4% +$4K 0.05% 108
2025
Q2 		$96.6K Buy
3,985
+442
+12% +$10.3K 0.05% 108
2025
Q1 		$89.8K Buy
3,543
+158
+5% +$4.13K 0.06% 104
2024
Q4 		$89.8K Sell
3,385
-676
-17% -$18.3K 0.06% 103
2024
Q3 		$118K Buy
4,061
+1,000
+33% +$29.2K 0.08% 90
2024
Q2 		$85.6K Buy
3,061
+300
+11% +$8.26K 0.06% 105
2024
Q1 		$76.6K Buy
2,761
+1,896
+219% +$52.6K 0.06% 111
2023
Q4 		$24.9K Buy
+865
New +$26.1K 0.02% 237

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

WealthCollab's PFE Position: Q2 2026 in Review

WealthCollab increased its Pfizer (PFE) stake by 13% in Q2 2026, buying an estimated $14.9K and bringing the position to 5,017 shares worth $121K. The position accounts for 0.04% of the portfolio, ranked #121.

WealthCollab first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $125K in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • WealthCollab held 5,017 shares of Pfizer worth $121K as of Q2 2026.
  • WealthCollab bought 570 Pfizer shares in Q2 2026, an estimated $14.9K.
  • Pfizer made up 0.04% of WealthCollab's portfolio in Q2 2026, its #121 holding.
  • WealthCollab first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • WealthCollab's Pfizer position peaked at $125K in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.